FDA Grants New Indication for Two Antiepileptic Drugs FDA Grants New Indication for Two Antiepileptic Drugs

Brivaracetam (Briviact) gets a monotherapy indication for partial-onset seizures in children 16 years and older, and eslicarbazepine acetate (Aptiom) is now approved for partial-onset seizures in children as young as 4 years.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Alert Source Type: news